Study Details

Back
Study ID 0113-CL-0004
Study Title A Phase 1, Single-Blind, Parallel-Group, Pharmacokinetic and Immunogenicity Study with ASP0113 in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
Clinicaltrials.gov Identifier NCT02103426
Compound Name ASP0113
Medical Indication or Disease Prevention of CMV infection
Study Sponsor Astellas Pharma Global Development, Inc.
Collaborator Not Applicable
Study Start Date 04-Dec-2013
Study Completion Date 10-May-2016
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
English

QUICK SEARCH

USEFUL LINKS